6534 Stock Overview
Develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
CH Biotech R&D Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$81.10 |
| 52 Week High | NT$114.50 |
| 52 Week Low | NT$72.10 |
| Beta | 0.41 |
| 11 Month Change | 3.58% |
| 3 Month Change | 5.05% |
| 1 Year Change | 0.87% |
| 33 Year Change | 54.67% |
| 5 Year Change | 39.88% |
| Change since IPO | 0.38% |
Recent News & Updates
Recent updates
CH Biotech R&D (GTSM:6534) Takes On Some Risk With Its Use Of Debt
Apr 05
A Look At CH Biotech R&D's (GTSM:6534) Share Price Returns
Mar 18Are CH Biotech R&D Co., Ltd.'s (GTSM:6534) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Feb 09
Returns On Capital At CH Biotech R&D (GTSM:6534) Paint An Interesting Picture
Jan 11Does CH Biotech R&D (GTSM:6534) Have A Healthy Balance Sheet?
Dec 15Tread With Caution Around CH Biotech R&D Co., Ltd.'s (GTSM:6534) 1.8% Dividend Yield
Nov 24Shareholder Returns
| 6534 | TW Chemicals | TW Market | |
|---|---|---|---|
| 7D | 0% | -2.8% | -0.6% |
| 1Y | 0.9% | -22.3% | 33.9% |
Return vs Industry: 6534 exceeded the TW Chemicals industry which returned -19.6% over the past year.
Return vs Market: 6534 underperformed the TW Market which returned 37.7% over the past year.
Price Volatility
| 6534 volatility | |
|---|---|
| 6534 Average Weekly Movement | 2.1% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6534 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6534's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Cho-Chun Huang | www.chbio.com |
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally. It offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd.
CH Biotech R&D Co., Ltd. Fundamentals Summary
| 6534 fundamental statistics | |
|---|---|
| Market cap | NT$8.34b |
| Earnings (TTM) | NT$381.23m |
| Revenue (TTM) | NT$1.50b |
21.9x
P/E Ratio5.5x
P/S RatioIs 6534 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6534 income statement (TTM) | |
|---|---|
| Revenue | NT$1.50b |
| Cost of Revenue | NT$256.44m |
| Gross Profit | NT$1.25b |
| Other Expenses | NT$866.41m |
| Earnings | NT$381.23m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.71 |
| Gross Margin | 82.95% |
| Net Profit Margin | 25.35% |
| Debt/Equity Ratio | 17.4% |
How did 6534 perform over the long term?
See historical performance and comparison